Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flow from operating activities:
Net loss	$ (3,293,184)	$ (1,760,022)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on equity method investment	439,637
Depreciation and amortization	39,526	18,167
Vesting expense for stock options	263,600	226,387
Amortization of debt discount	468,564
Loss on valuation of equity-linked instruments	19,408
Changes in assets and liabilities:
Accounts receivable	59,159	(104,265)
Inventories	(47,957)	(7,511)
Prepaid expense and other assets	(3,273)	81,661
Accounts payable	(13,491)	45,847
Accrued expenses	21,494	(226,775)
Deferred revenue	(2,136)	32,193
Net cash used in operating activities	(2,048,653)	(1,694,318)
Cash flow from investing activities:
Redemption of certificates of deposit		244,971
Advance on notes receivable	(631,316)	(42,524)
Purchase of fixed assets		(32,789)
Transfer of fixed assets to inventory	9,863
Acquisition of intangibles	(3,198)	(24,029)
Net cash (used in) provided by investing activities:	(624,651)	145,629
Cash flow from financing activities:
Extinguishment of convertible debt	(93,827)
Proceeds from debt issuance	1,250,000
Proceeds from exercise of warrants into common stock		55,794
Issuance of common stock	2,479,709	2,959,509
Net cash provided by financing activities	3,635,882	3,015,303
Net increase in cash and cash equivalents	962,578	1,466,614
Cash at beginning of period	162,152	766,189
Cash at end of period	1,124,730	2,232,803
Non-cash transactions:
Bridge loan conversion into common stock	90,000
Forbearance settlement bridge loan	503,009
Additional warrants issued pursuant to CEO note payable	8,665
Conversion of preferred stock to common stock		6,479
Equity method investment - Helomics		$ 1,542,250